投融资数据库
免费查数据
注册送3天会员
首页>投融资
HistoSonics
未公开
HistoSonics is a privately held medical device company developing a non-invasive platform and proprietary sonic beam therapy utilizing the science of histotripsy, a novel mechanism of action that uses focused ultrasound to mechanically destroy and liquify unwanted tissue and tumors at sub-cellular levels.In December 2022, HistoSonics Inc announced raised $85 million in a financing led by Johnson & Johnson Innovation with participation from existing investors including Venture Investors, Lumira Ventures, Yonjin Venture, and the State of Wisconsin Investment Board, among others
基本信息
-
公司全称Histosonics Inc
-
类型机器人辅助声波疗法研发商
-
产业领域医疗器械
-
公司人数15~50人
-
地址3626 West Liberty Road Suite 100 ANN ARBOR MICHIGAN 48103; US; Telephone: +17349264633;
-
联系电话734-926-4630
-
邮箱info@histosonics.com
-
成立时间2009-01-01
投融资
-
2025-10-16
-
2025-08-07
-
2024-08-15
-
2022-12-13
-
2022-12-13
-
2020-06-08
-
2020-01-13
-
2019-04-08
-
2018-07-13
-
2017-03-13
-
2015-09-03
-
2010-04-20
- 加载更多
相关投融资企业
C轮
Akura Medical是Shifamed LLC的一家私人控股投资组合公司,正在开发下一代血栓切除设备,旨在通过一种易于使用的单程程序来简化血栓切除术,该程序可有效去除血栓。
收并购
Acera Surgical Inc develops and commercializes synthetic materials for regenerative medical applications
C轮
Okami Medical, Inc.是一家私有医疗器械公司,其使命是通过开发创新、多功能和直观的闭塞血管器械来满足患者和医生不断发展的需求。
目前Okami已开发出LOBO™血管闭塞系统,该系统的独特设计旨在为介入治疗的医生提供单设备,即一劳永逸的解决方案,从而无需多种栓塞设备即可阻塞多种动脉靶标。



浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息